| Trial ID: | L4670 |
| Source ID: | NCT00190502
|
| Associated Drug: |
Polyclonal Anti-T-Cell Antibodies
|
| Title: |
Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: Polyclonal anti-T-cell antibodies
|
| Outcome Measures: |
Primary: C-peptide production | Secondary: Diabetes remission rate|Insulin dose
|
| Sponsor/Collaborators: |
Sponsor: Institute for Clinical and Experimental Medicine | Collaborators: Ministry of Health, Czech Republic
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
|
| Enrollment: |
28
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: ECT
|
| Start Date: |
2000-11
|
| Completion Date: |
2007-12
|
| Results First Posted: |
|
| Last Update Posted: |
2007-01-09
|
| Locations: |
Institute for Clinical and Experimental Medicine, Department of Diabetes, Prague, 14021, Czech Republic
|
| URL: |
https://clinicaltrials.gov/show/NCT00190502
|
